Basic Information
Basic information for CT69-209-41aa
Peptide Name CT69-209-41aa
Genome Position chr6:134475116-134475123,134476395-134476509[-]
Species Human
Peptide Sequence MDEAGNRHSQQTNIRTENQTPHVLTHKWELNNENTWTRAVT
Peptide Length 41
Unique No (CT69-211-41aa,CT69-212-41aa)
Grand Average of Hydropathicity -1.4512
Relative Molecular Mass 5580.11
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000231971;CT69
Transcript ID/Name ENST00000661465;CT69-209
Transcript Length 606
Coding Ability 0.5264
DNA Sequence Corresponding to Peptide ATGGATGAAGCTGGAAACCGTCATTCTCAGCAAACTAACATAAGAACAGAAAACCAAACACCACATGTCCTCACTCATAAGTGGGAGTTGAACAATGAGAATACATGGACACGGGCAGTGACC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :